The Longevity Week: Addressing global Longevity

Latest articles

Peptide therapeutics company targets age-related disease

Gray Matter working with Insilico Medicine to identify peptide targets and accelerate development timeline for age-related disease therapies. Earlier this month, we brought you the...

Buck researchers provide a framework to study precision nutrigeroscience

One size doesn't fit all – a new research sub-specialty deals with the fact that health benefits from many forms of dietary restriction vary...

Accelerating antiaging research by hacking longevity

Bringing together aging researchers, developers and entrepreneurs, the Longevity Hackathon aims to build new tools, raise awareness and attract talent to the field. Kicking off...

X marks the spot for meaningful information on aging and cognition

Understanding chromosomal differences between men and women could be the X Factor when it comes to tackling cognitive decline. A new paper published in Jama...

Most read

Tree of Longevity – understanding how supplements work

Pathways? Hallmarks? Biomarkers? Understanding the longevity supplements lingo can help you make better choices for your healthspan. Longevity supplements differ from other 'generic supplements' as...

Berberine could be longevity’s “best-kept secret”

From tackling senescence to lowering blood sugar, berberine is the supplement with a host of tricks up its sleeves. Berberine is a bioactive compound found...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Editor's picks

Peptide therapeutics company targets age-related disease

Gray Matter working with Insilico Medicine to identify peptide targets and accelerate development timeline for age-related disease therapies. Earlier this month, we brought you the...

Buck researchers provide a framework to study precision nutrigeroscience

One size doesn't fit all – a new research sub-specialty deals with the fact that health benefits from many forms of dietary restriction vary...

Accelerating antiaging research by hacking longevity

Bringing together aging researchers, developers and entrepreneurs, the Longevity Hackathon aims to build new tools, raise awareness and attract talent to the field. Kicking off...

Click the globe for translations.

A packed week of multidisciplinary events with a global focus on the Longevity challenge.

One year ago, the first Longevity Forum event was held in London. Its main objective: To facilitate the exchange of ideas between experts from the fields of science and social science to explore the opportunities presented by increases in human longevity. The brainchild of founders Jim Mellon, Andrew Scott and Dafina Grapci-Penney, the forum was created as a place where cutting-edge ideas would be generated, debated and critiqued.

This year, with a growing network of individuals and organisations spanning the worlds of government, business, finance, research, academia and NGOs across sectors and countries, it was felt more time was needed to address all the multidisciplinary topics connected to global Longevity. So, for 2019, the scope of the Forum has been expanded to include a full week of events focused on helping people achieve longer, healthier and more fulfilled lives: The Longevity Week.

The theme of The Longevity Week is Longevity 2030 – a deeper dive into the ideas and innovations that will shape humanity in the next 10 years. The week’s events will explore a wide range of subjects, including:

Ovarian Longevity webinar
  • The ever-expanding boundaries of science and technology
  • The economic opportunities presented by longevity and implications for governments and individuals
  • The policy agenda supporting educational, healthcare and social care systems to ensure they are fit for the future
  • The relationship between humans and machines, and the governance framework needed to ensure that this growing interdependence can help humans achieve their full potential

Key Highlights

On Monday, Andrew Scott presents a kick-off event in Singapore The Global Longevity Agenda, which is one of The Longevity Forum’s flagship initiatives and developed in conjunction with the Stanford Center on Longevity. There he will discuss the findings of an initiative, which outlined the principles that make longevity distinct from aging, and set high level objectives which governments around the world need to achieve in the next 10 years to support the longevity agenda.

On Tuesday, at Oriel College in Oxford, Jim Mellon welcomes delegates to the Science Summit, which brings together leading experts in the field of longevity research to discuss their most recent findings with fellow researchers, investors and entrepreneurs working in the field. Meanwhile, at Kings College in London, the International Longevity Policy and Governance Summit will host the world’s first international, cross-border, cross-sector summit on the current state of international Longevity policy and governance.

Ovarian Longevity webinar

The centrepiece of The Longevity Week is Thursday’s Annual Longevity Form. The forum is a full day of discussion involving a wide range of speakers from many different disciplines and countries, all focused how to achieve a step change in both the policy and attitudes which are required for societies to reap a significant longevity dividend and maximise the return on Longevity. Key speakers at this year’s annual forum include Dr Nir Barzilai, Founding Director of the Institute for Aging at The Albert Einstein College of Medicine, Andy Briggs, Co-Chair of the new UK Longevity Council, and Dr Linda Fried, Dean of the Mailman School of Public Health at Columbia University, and many more.


Longevity.Technology’s editor in chief, Philip Newman, will be in attendance at several of the Longevity Week events. If you’d like to connect with him next week, be sure to get in touch.

Danny Sullivan
Contributing Editor Danny has worked in technology communications for more than 15 years, spanning Europe and North America. From bionics and lasers to software and pharmaceuticals – and everything in between – he’s covered it all. Danny has wide experience of technology publishing and technical writing and has specific interest in the transfer from idea to market.

Most popular

Tree of Longevity – understanding how supplements work

Pathways? Hallmarks? Biomarkers? Understanding the longevity supplements lingo can help you make better choices for your healthspan. Longevity supplements differ from other 'generic supplements' as...

Berberine could be longevity’s “best-kept secret”

From tackling senescence to lowering blood sugar, berberine is the supplement with a host of tricks up its sleeves. Berberine is a bioactive compound found...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Spermidine: the mind-enhancing supplement

Scientists are finding that a high intake of dietary spermidine could slow down (or reverse) the brain aging process. Memory loss and slower brain function...

Related articles

SENS spin-out Underdog closes $10m financing round

Underdog Pharmaceuticals, a key investment of rejuvenation biotech VC Kizoo, has closed a $10 million round of capital. Michael Greve’s Kizoo Technology Capital Group led the...

Unlocking ovarian aging could prolong fertility and delay menopause

Ovarian aging is poorly understood, under-researched and under-invested. We need a radical rethink of how we address fertility and the menopause – it's time...

Occuity raises over £2.5m for optical diabetes devices

UK MedTech firm Occuity successfully raises over £2.5m to deliver ophthalmic and optical diabetes devices and is now overfunding on Seedrs to accelerate development. DISCLOSURE:...

Fauna closes $9 million to expand drug discovery platform

Leveraging animal genomics to improve human health, Fauna Bio set to expand its comparative genomics platform for novel target drug discovery. Silicon Valley biotech startup...

Targeting cognitive decline with medical food

Mitocholine raising funding for clinical trial of nutritional compound that addresses cognitive decline by bridging the ‘brain energy gap’. DISCLOSURE: Longevity.Technology (a brand of First...
Nutriop